Disruption of YPS1 and PEP4 genes reduces proteolytic degradation of secreted HSA/PTH in Pichia pastoris GS115

Min Wu, Qi Shen, Yong Yang, Sheng Zhang, Qu Wen, Jing Chen, Hongying Sun, Shuqing ChenJournal of Industrial Microbiology & Biotechnology 2013 · DOI

TL;DR

This paper tackles the challenge of producing intact human parathyroid hormone (PTH) fused to human serum albumin (HSA) in Pichia pastoris, a common expression system. By identifying and disrupting key yeast protease genes (PEP4 and YPS1), the researchers significantly reduced protein degradation, achieving an 80% yield of intact HSA/PTH fusion protein, a substantial improvement over the wild-type strain's 30%.

What Problem Does This Paper Address?

The development of effective treatments for osteoporosis often involves therapeutic proteins like parathyroid hormone (PTH). However, native PTH has a very short half-life in the body, necessitating frequent injections. Fusing PTH to human serum albumin (HSA) is a strategy to extend its half-life, making it a more practical therapeutic. The authors aimed to produce an HSA/PTH (1-34) fusion protein in Pichia pastoris, a widely used yeast for recombinant protein production. The primary hurdle they encountered was significant proteolytic degradation of the fusion protein during secretion, leading to low yields of the desired intact product and complicating purification. This degradation resulted in multiple smaller fragments, including a known ~45 kDa HSA-truncated fragment and other ~66 kDa fragments, hindering the efficient production of a pure, active therapeutic.

Methods

The researchers employed a combination of molecular biology techniques and protein analysis methods:

  • Gene Disruption: They systematically knocked out specific protease genes in the Pichia pastoris GS115 strain. This involved creating single gene knockouts for seven "yapsin" genes (a family of aspartyl proteases) and two major vacuolar proteases (PEP4 encoding proteinase A, and PRB1 encoding proteinase B). They also created double knockouts, most notably a pep4 and yps1 double disruptant.
  • Recombinant Protein Expression: The HSA/PTH (1-34) fusion protein was expressed in both wild-type and engineered Pichia pastoris strains using a standard methanol-inducible expression system.
  • Protein Analysis:
    • SDS-PAGE and Native PAGE: These gel electrophoresis techniques were used to separate and visualize the different protein fragments present in the culture supernatant. SDS-PAGE separates by size, while native PAGE separates by size and charge, providing complementary information.
  • Western Blotting: This technique was used to specifically detect the presence of HSA and PTH epitopes in the different protein fragments, helping to identify which parts of the fusion protein were being cleaved.
  • MALDI-TOF Mass Spectrometry: This was used to accurately determine the molecular weight of the purified intact HSA/PTH (1-34) fusion protein, confirming its identity.
  • Quantitative Analysis: Densitometry of PAGE gels was used to quantify the relative abundance of intact protein versus degradation fragments.

Datasets

Not discussed in the paper. The study focuses on experimental data generated from engineered yeast strains and their secreted proteins.

Key Insights and Ideas

  • Protease Identification is Key: The study successfully identified specific yeast proteases (PEP4 and YPS1) as major contributors to the degradation of the HSA/PTH (1-34) fusion protein. This highlights the importance of understanding and manipulating host cell proteases for efficient heterologous protein production.
  • Synergistic Degradation: While single gene disruptions showed some improvement, the double disruption of PEP4 and YPS1 yielded the most significant reduction in degradation. This suggests that multiple protease pathways are involved and that targeting key players can have a synergistic effect.
  • Targeted Protease Engineering: The ability to reduce specific degradation fragments (e.g., PEP4 disruption reducing fragment dl, and YPS1 disruption reducing fragment d2) demonstrates a level of control over the degradation process.
  • Implications for Biopharmaceutical Production: The findings have direct implications for the industrial production of therapeutic proteins. By engineering protease-deficient strains, the yield and purity of valuable recombinant proteins can be substantially improved, leading to more cost-effective manufacturing.

Key Results

  • Wild-type Degradation: In the wild-type Pichia pastoris GS115 strain, only about 30% of the secreted HSA/PTH (1-34) remained intact after 72 hours of induction.
  • Single Gene Disruption Benefits:
    • Disrupting PEP4 (proteinase A) alone reduced the formation of fragment dl.
  • Disrupting YPS1 (a yapsin) alone significantly reduced the formation of fragment d2.
  • Double Gene Disruption Success: The double disruptant (pep4△yps1△) showed the most dramatic improvement, with over 80% of the secreted HSA/PTH (1-34) remaining intact after 72 hours of induction.
  • Fed-batch Fermentation: The superior performance of the pep4△yps1△ strain was also confirmed in fed-batch fermentation, where intact protein levels remained high for a longer duration compared to the wild-type strain.

Limitations and Future Work

  • Incomplete Elimination: While degradation was significantly reduced, it was not completely eliminated, even in the double disruptant. This suggests that other proteases might also contribute to degradation, or that the remaining proteases still have some activity.
  • Yapsin Family Complexity: The study focused on seven yapsin genes, but the authors acknowledge that a more comprehensive analysis of multiple yapsin disruptions might be necessary to achieve complete inhibition.
  • Optimization of Fermentation: The authors suggest that further optimization of the fermentation process for the pep4△yps1△ strain is needed to further minimize protein loss.
  • Broader Applicability: While this study focused on HSA/PTH (1-34), the principles of protease disruption could be applied to other recombinant proteins that are susceptible to degradation in Pichia pastoris. Future work could explore the effectiveness of these disruptions on other sensitive proteins.
  • Systematic Protease Analysis: The authors propose that with the availability of the Pichia pastoris genome sequence, systematic analyses of a wider range of proteases could be facilitated for developing even more robust production systems.

Summary updated

Abstract

Human serum albumin (HSA) and human parathyroid hormone (1-34) [PTH (1-34)] fusion protein [HSA/PTH (1-34)] is a promising long-acting form of PTH (1-34) for osteoporosis treatment. Secretory expression of intact HSA/PTH (1-34) in Pichia pastoris GS115 was accompanied by two degradation fragments, with molecular weights around 66 kDa, in addition to the well-known ~45 kDa HSA-truncated fragment, resulting in a low yield of intact protein. In this study, two internal cleavage sites were identified in the PTH (1-34) portion of the fusion protein by Western Blot analysis. To minimize proteolytic cleavages, several protease genes including PEP4 (encoding proteinase A), PRB1 (proteinase B) and seven YPSs genes (yapsin family members) were knocked out respectively by disruption of the individual genes and the selective combinations. Reduced degradation was observed by single disruption of either PEP4 gene or YPS1 gene, and the lowest level of degradation was observed in a pep4△yps1△ double disruptant. After 72 h of induction, more than 80 % of the HSA/PTH (1-34) secreted by the pep4△yps1△ double disruptant remained intact, in comparison to only 30 % with the wild-type strain.
BibTeX
@article{wu2013disruption,
  author = {Min Wu and Qi Shen and Yong Yang and Sheng Zhang and Qu Wen and Jing Chen and Hongying Sun and Shuqing Chen},
  title = {{Disruption of <i>YPS1</i> and <i>PEP4</i> genes reduces proteolytic degradation of secreted HSA/PTH in <i>Pichia pastoris</i> GS115}},
  journal = {Journal of Industrial Microbiology \& Biotechnology},
  year = {2013},
  doi = {10.1007/s10295-013-1264-8},
}
Figure